Whitehawk Therapeutics, Inc. Common Stock WHWK Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$22.19M-130% | -$23.25M-27.2% | -$17.75M-41.4% | -$52.62M-261% | $73.02M+499% | ||
| $1K-98.2% | $1K-97.9% | $5.6K-88.0% | $15.3K-69.2% | $57K+14.0% | ||
| $2.19M+30.5% | $2.39M+28.8% | $2.72M+6.3% | $3.09M+8.7% | $1.68M-53.2% | ||
| $0-100% | $0— | -$177K— | $0— | $87.44M— | ||
| $0-100% | —— | —— | —— | $1M+280% | ||
| -$0+100% | —— | —— | —— | -$170K+65.3% | ||
| -$3.49M-458% | $4.67M— | $985K+116% | -$2.71M— | $975K+114% | ||
| -$163K-43.0% | —— | —— | $880K+865% | -$114K+17.4% | ||
| $0+100% | —— | —— | —— | -$202K— | ||
| $0+100% | —— | —— | —— | -$89K+29.4% | ||
| -$22.21M-87.2% | -$17.23M-14.5% | -$15.38M+2.0% | -$52.96M-478% | -$11.86M+39.6% | ||
| $0-100% | —— | —— | $1K-99.8% | $551K-25.4% | ||
| $19.19M— | $22.92M— | $93.56M+842% | $32.22M+70.4% | $0-100% | ||
| $38.62M+163% | $39.76M+199% | $2M-86.9% | $3.39M-78.7% | $14.69M-22.4% | ||
| $0-100% | —— | —— | —— | $101.36M— | ||
| $19.43M-83.2% | $16.85M+28.3% | -$91.63M-1,902% | —— | $115.5M+994% | ||
| $0-100% | —— | —— | $5K— | $21K— | ||
| $0-100% | $25K-52.8% | —— | —— | $95.2M+952,110% | ||
| -$2.78M-101% | —— | —— | —— | $198.84M+2,283% | ||
| $347K+1,926% | $831K+354% | $717K+132% | -$2K-101% | -$19K-105% | ||
| $1K-98.2% | —— | $5.6K-88.0% | $15.3K-69.2% | $57K+14.0% | ||
| $0-100% | $0— | -$177K— | $0— | $87.44M— | ||
| $0+100% | —— | —— | —— | -$89K+29.4% | ||
| -$1.47M-92.2% | $375K+280% | $965K+639% | -$141K+90.4% | -$765K+19.7% | ||
| $0-100% | —— | —— | —— | $74K-35.7% | ||
| $0-100% | —— | —— | —— | $101.36M— | ||
| $38.62M+163% | $39.76M+199% | $2M-86.9% | $3.39M-78.7% | $14.69M-22.4% | ||
| $0-100% | —— | —— | $803K— | $4.82M— | ||
| $0-100% | —— | —— | —— | $100M— | ||
| $30K-82.0% | —— | —— | —— | $167K— | ||
| $0+100% | —— | —— | —— | -$89K+29.4% | ||
| $0-100% | —— | —— | —— | $632K— | ||
| -$22.21M-78.9% | -$17.23M-13.1% | -$15.38M+3.1% | -$52.96M-446% | -$12.42M+39.1% | ||
| -$22.21M-78.9% | -$17.23M-13.1% | -$15.38M+3.1% | -$52.96M-446% | -$12.42M+39.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Whitehawk Therapeutics, Inc. Common Stock generate?
- Whitehawk Therapeutics, Inc. Common Stock (WHWK) generated -$107.8M in operating cash flow over the trailing twelve months.
- What is Whitehawk Therapeutics, Inc. Common Stock's free cash flow?
- After $738.0K of capital expenditures, Whitehawk Therapeutics, Inc. Common Stock's free cash flow was -$107.8M over the trailing twelve months, down 102.5% year over year.
- Where does Whitehawk Therapeutics, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Whitehawk Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.